| Literature DB >> 19919087 |
Patrick R Verhoest1, Caroline Proulx-Lafrance, Michael Corman, Lois Chenard, Christopher J Helal, Xinjun Hou, Robin Kleiman, Shenping Liu, Eric Marr, Frank S Menniti, Christopher J Schmidt, Michelle Vanase-Frawley, Anne W Schmidt, Robert D Williams, Frederick R Nelson, Kari R Fonseca, Spiros Liras.
Abstract
By use of chemical enablement and prospective design, a novel series of selective, brain penetrant PDE9A inhibitors have been identified that are capable of producing in vivo elevations of brain cGMP.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19919087 DOI: 10.1021/jm9015334
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446